TY - JOUR
T1 - Cytokine modulation of nuclear factor-κB activity in B-chronic lymphocytic leukemia
AU - Zaninoni, Anna
AU - Imperiali, Francesca Guia
AU - Pasquini, Cristina
AU - Zanella, Alberto
AU - Barcellini, Wilma
PY - 2003/3/1
Y1 - 2003/3/1
N2 - Objective. Dysregulation of the apoptotic mechanisms plays a key role in the accumulation of malignant B-chronic lymphocytic leukemia (B-CLL) cells. The transcription nuclear factor (NF)-κB is important for cell survival by regulating the expression of anti-apoptotic genes. Several cytokines can modulate leukemic growth and apoptosis in B-CLL. The aim of this study was to determine whether cytokine-mediated regulation of apoptosis occurs via modulation of NF-κB activity in peripheral blood mononuclear cells from B-CLL patients. Patients and Methods. We evaluated NF-κB activity in peripheral blood mononuclear cells from 15 untreated B-CLL patients and 11 controls in resting conditions and in the presence of phorbol-12-myristate-13-acetate (PMA) and different cytokines by electrophoretic mobility shift assay. Apoptosis was studied by spectrophotometric analysis of DNA fragmentation. Results. We found a constitutive high NF-κB activity not induced by PMA in B-CLL patients, in contrast with a normal inducible NF-κB activity in controls. In B-CLL cultures, addition of interleukin (IL)-4 and IL-13 increased, whereas transforming growth factor (TGF)-β reduced NF-κB activity compared with unstimulated cultures. Accordingly, IL-4 and IL-13 decreased, whereas TGF-β increased DNA fragmentation compared with unstimulated cultures. IL-13 and IL-4 production was increased, whereas TGF-β was reduced in PMA-stimulated and unstimulated cultures from B-CLL patients compared with controls. Conclusions. B-CLL patients have a constitutive high NF-κB activity, which is modulated by cytokines. In particular, TGF-β displays a pro-apoptotic activity, whereas IL-4 and IL-13 have opposite effects. These cytokine alterations could be responsible for a positive autocrine circuit that maintains leukemic cells in a pre-apoptotic state.
AB - Objective. Dysregulation of the apoptotic mechanisms plays a key role in the accumulation of malignant B-chronic lymphocytic leukemia (B-CLL) cells. The transcription nuclear factor (NF)-κB is important for cell survival by regulating the expression of anti-apoptotic genes. Several cytokines can modulate leukemic growth and apoptosis in B-CLL. The aim of this study was to determine whether cytokine-mediated regulation of apoptosis occurs via modulation of NF-κB activity in peripheral blood mononuclear cells from B-CLL patients. Patients and Methods. We evaluated NF-κB activity in peripheral blood mononuclear cells from 15 untreated B-CLL patients and 11 controls in resting conditions and in the presence of phorbol-12-myristate-13-acetate (PMA) and different cytokines by electrophoretic mobility shift assay. Apoptosis was studied by spectrophotometric analysis of DNA fragmentation. Results. We found a constitutive high NF-κB activity not induced by PMA in B-CLL patients, in contrast with a normal inducible NF-κB activity in controls. In B-CLL cultures, addition of interleukin (IL)-4 and IL-13 increased, whereas transforming growth factor (TGF)-β reduced NF-κB activity compared with unstimulated cultures. Accordingly, IL-4 and IL-13 decreased, whereas TGF-β increased DNA fragmentation compared with unstimulated cultures. IL-13 and IL-4 production was increased, whereas TGF-β was reduced in PMA-stimulated and unstimulated cultures from B-CLL patients compared with controls. Conclusions. B-CLL patients have a constitutive high NF-κB activity, which is modulated by cytokines. In particular, TGF-β displays a pro-apoptotic activity, whereas IL-4 and IL-13 have opposite effects. These cytokine alterations could be responsible for a positive autocrine circuit that maintains leukemic cells in a pre-apoptotic state.
UR - http://www.scopus.com/inward/record.url?scp=0037336974&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0037336974&partnerID=8YFLogxK
U2 - 10.1016/S0301-472X(02)01046-9
DO - 10.1016/S0301-472X(02)01046-9
M3 - Article
C2 - 12644014
AN - SCOPUS:0037336974
VL - 31
SP - 185
EP - 190
JO - Experimental Hematology
JF - Experimental Hematology
SN - 0301-472X
IS - 3
ER -